
Acting FDA commissioner calls for independent investigation into approval of Alzheimer's drug
CNN
US Food and Drug Administration Acting Commissioner Dr. Janet Woodcock on Friday requested an investigation by the US Department of Health and Human Services Office of Inspector General into the controversial approval of the Alzheimer's disease drug Aduhelm.
In a letter posted on Twitter, Woodcock said an independent review and assessment should consider interactions between Biogen, the company that makes Aduhelm, and the FDA during the process that led to the June approval of the drug.More Related News

President Donald Trump issued a stark threat to defense contracting companies on Wednesday, saying he would seek to limit stock buybacks and executive salaries unless they improve their delivery of weapons systems to the US military hours before saying he’d decided to substantially increase the defense budget.












